Effects of risedronate and low-dose transdermal testosterone on bone mineral
density in women with anorexia nervosa: a randomized, placebo-controlled study.
Author(s): Miller KK, Meenaghan E, Lawson EA, Misra M, Gleysteen S, Schoenfeld D, Herzog D,
Klibanski A.
Affiliation(s): Neuroendocrine Unit, Massachusetts General Hospital, Boston, Massachusetts 02114,
USA. KKMiller@Partners.org
Publication date & source: 2011, J Clin Endocrinol Metab. , 96(7):2081-8
CONTEXT: Anorexia nervosa is complicated by severe bone loss and clinical
fractures. Mechanisms underlying bone loss in adults with anorexia nervosa
include increased bone resorption and decreased formation. Estrogen
administration has not been shown to prevent bone loss in this population, and to
date, there are no approved, effective therapies for this comorbidity.
OBJECTIVE: To determine whether antiresorptive therapy with a bisphosphonate
alone or in combination with low-dose transdermal testosterone replacement would
increase bone mineral density (BMD) in women with anorexia nervosa.
DESIGN AND SETTING: We conducted a12-month, randomized, placebo-controlled study
at a clinical research center.
STUDY PARTICIPANTS: Participants included 77 ambulatory women with anorexia
nervosa.
INTERVENTION: Subjects were randomized to risedronate 35 mg weekly, low-dose
transdermal testosterone replacement therapy, combination therapy or double
placebo.
MAIN OUTCOME MEASURES: BMD at the spine (primary endpoint), hip, and radius and
body composition were measured by dual-energy x-ray absorptiometry.
RESULTS: Risedronate increased posteroanterior spine BMD 3%, lateral spine BMD
4%, and hip BMD 2% in women with anorexia nervosa compared with placebo in a
12-month clinical trial. Testosterone administration did not improve BMD but
increased lean body mass. There were few side effects associated with either
therapy.
CONCLUSIONS: Risedronate administration for 1 yr increased spinal BMD, the
primary site of bone loss in women with anorexia nervosa. Low-dose testosterone
did not change BMD but increased lean body mass.
|